Transcranial magnetic stimulation: a novel biomarker to predict cognitive decline and response to therapy in Alzheimer’s disease patients
Main Author: | G. Koch |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-03-01
|
Series: | Brain Stimulation |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1935861X18310817 |
Similar Items
-
Transcranial Magnetic Stimulation Studies in Alzheimer's Disease
by: Andrea Guerra, et al.
Published: (2011-01-01) -
Repetitive transcranial magnetic stimulation treatment in Alzheimer's disease
by: J. Lee, et al.
Published: (2017-03-01) -
The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease
by: Alberto Benussi, et al.
Published: (2018-09-01) -
Therapeutic effect of repetitive transcranial magnetic stimulation with cognitive training in mild to severe Alzheimer disease
by: A. Lee, et al.
Published: (2019-03-01) -
Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations
by: Nicholas C. Cullen, et al.
Published: (2021-06-01)